HomeCompareNVFY vs MRK

NVFY vs MRK: Dividend Comparison 2026

NVFY yields 32.36% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVFY wins by $94.8K in total portfolio value
10 years
NVFY
NVFY
● Live price
32.36%
Share price
$6.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$151.6K
Annual income
$21,410.50
Full NVFY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NVFY vs MRK

📍 NVFY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVFYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVFY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVFY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVFY
Annual income on $10K today (after 15% tax)
$2,750.81/yr
After 10yr DRIP, annual income (after tax)
$18,198.93/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NVFY beats the other by $9,870.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVFY + MRK for your $10,000?

NVFY: 50%MRK: 50%
100% MRK50/50100% NVFY
Portfolio after 10yr
$104.2K
Annual income
$15,604.32/yr
Blended yield
14.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NVFY
No analyst data
Altman Z
7.9
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVFY buys
0
MRK buys
0
No recent congressional trades found for NVFY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVFYMRK
Forward yield32.36%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$151.6K$56.8K
Annual income after 10y$21,410.50$9,798.13
Total dividends collected$106.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NVFY vs MRK ($10,000, DRIP)

YearNVFY PortfolioNVFY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,936$3,236.25$11,206$366.19+$2.7KNVFY
2$19,127$4,215.06$12,650$502.35+$6.5KNVFY
3$25,872$5,406.51$14,407$694.19+$11.5KNVFY
4$34,518$6,834.77$16,585$967.82+$17.9KNVFY
5$45,457$8,522.22$19,342$1,363.89+$26.1KNVFY
6$59,127$10,488.64$22,913$1,947.19+$36.2KNVFY
7$76,017$12,750.46$27,662$2,823.89+$48.4KNVFY
8$96,658$15,320.15$34,159$4,173.35+$62.5KNVFY
9$121,630$18,205.74$43,337$6,308.80+$78.3KNVFY
10$151,554$21,410.50$56,776$9,798.13+$94.8KNVFY

NVFY vs MRK: Complete Analysis 2026

NVFYStock

Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.

Full NVFY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NVFY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVFY vs SCHDNVFY vs JEPINVFY vs ONVFY vs KONVFY vs MAINNVFY vs JNJNVFY vs ABBVNVFY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.